Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diabetes Mellitus Increases Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients: A Systematic Review
Harleen K. Dyal, María Aguilar, G Bartos, et al.
Digestive Diseases and Sciences (2015) Vol. 61, Iss. 2, pp. 636-645
Closed Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Susceptibility for Some Infectious Diseases in Patients With Diabetes: The Key Role of Glycemia
Jesús Chávez‐Reyes, Carlos Enrique Escárcega‐González, Erika Chavira-Suárez, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 110
Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease
Alessandro Mantovani, Giovanni Targher
Annals of Translational Medicine (2017) Vol. 5, Iss. 13, pp. 270-270
Open Access | Times Cited: 140
Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada
Naveed Z. Janjua, Mei Chong, Margot Kuo, et al.
Journal of Hepatology (2016) Vol. 66, Iss. 3, pp. 504-513
Closed Access | Times Cited: 94
Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link
Lampros Chrysavgis, Ilias Giannakodimos, Panagiota Diamantopoulou, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 3, pp. 310-331
Open Access | Times Cited: 56
Impact of diabetes, obesity, and dyslipidemia on the risk of hepatocellular carcinoma in patients with chronic liver diseases
Hwang Sik Shin, Baek Gyu Jun, Sang‐Wook Yi
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 4, pp. 773-789
Open Access | Times Cited: 49
Risk of Hepatocellular Cancer in U.S. Patients With Compensated Cirrhosis Treated With Direct‐Acting Antivirals Versus Interferon
Hashem B. El‐Serag, Hao T. Duong, Michelle Luster, et al.
Alimentary Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 1
Direct‐acting antiviral treatment for hepatitis C virus infection and risk of incident liver cancer: a retrospective cohort study
A. Singer, K. Rajender Reddy, Laura Telep, et al.
Alimentary Pharmacology & Therapeutics (2018) Vol. 47, Iss. 9, pp. 1278-1287
Open Access | Times Cited: 80
2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations
Ashish Kumar, Subrat Kumar Acharya, Shivaram Prasad Singh, et al.
Journal of Clinical and Experimental Hepatology (2019) Vol. 10, Iss. 1, pp. 43-80
Open Access | Times Cited: 75
Diabetes Mellitus and Risk of Hepatocellular Carcinoma
Xu Li, Xiaocong Wang, Pujun Gao
BioMed Research International (2017) Vol. 2017, pp. 1-10
Open Access | Times Cited: 72
Metabolic complications of hepatitis C virus infection
Rahul Chaudhari, Sherouk Fouda, Ashik Sainu, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 13, pp. 1267-1282
Open Access | Times Cited: 49
Development and prognosis of hepatocellular carcinoma in patients with diabetes
T. Nakatsuka, Ryosuke Tateishi
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. 1, pp. 51-64
Open Access | Times Cited: 36
A Historical Overview on the Role of Hepatitis B and C Viruses as Aetiological Factors for Hepatocellular Carcinoma
Tommaso Stroffolini, Giacomo Stroffolini
Cancers (2023) Vol. 15, Iss. 8, pp. 2388-2388
Open Access | Times Cited: 21
Nuclear translocation of metabolic enzyme PKM2 participates in high glucose-promoted HCC metastasis by strengthening immunosuppressive environment
Jiali Qian, Chuxin Huang, Mimi Wang, et al.
Redox Biology (2024) Vol. 71, pp. 103103-103103
Open Access | Times Cited: 6
Risk of de novo HCC in patients with MASLD following direct-acting antiviral-induced cure of HCV infection
Chen‐Hua Liu, Pin‐Nan Cheng, Yu‐Jen Fang, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 6
Current level of evidence on causal association between hepatitis C virus and type 2 diabetes: A review
Giacomo Gastaldi, Nicolas Goossens, Sophie Clément, et al.
Journal of Advanced Research (2016) Vol. 8, Iss. 2, pp. 149-159
Open Access | Times Cited: 51
Type 2 diabetes mellitus increases the risk of hepatocellular carcinoma in subjects with chronic hepatitis B virus infection: a meta-analysis and systematic review
Yifei Tan, Shiyou Wei, Wei Zhang, et al.
Cancer Management and Research (2019) Vol. Volume 11, pp. 705-713
Open Access | Times Cited: 50
Serum Vitamin D Levels and Risk of Liver Cancer: A Systematic Review and Dose-Response Meta-Analysis of Cohort Studies
Yonggui Zhang, Xuefeng Jiang, Xiangjun Li, et al.
Nutrition and Cancer (2020) Vol. 73, Iss. 8, pp. 1-9
Closed Access | Times Cited: 48
Metabolic management after sustained virologic response in elderly patients with hepatitis C virus: A multicenter study
Tomoya Sano, Keisuke Amano, Tatsuya Ide, et al.
Hepatology Research (2023) Vol. 54, Iss. 4, pp. 326-335
Closed Access | Times Cited: 14
The Role of Hepatitis Viruses as Drivers of Hepatocancerogenesis
Mario Capasso, Valentina Cossiga, Maria Guarino, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1505-1505
Open Access | Times Cited: 5
Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight
Stefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 3, pp. 355-355
Open Access | Times Cited: 46
Extrahepatic manifestations associated with Chronic Hepatitis C Virus Infection.
Alejandra Flores-Chávez, J.A. Carrión, Xavier Forns, et al.
DOAJ (DOAJ: Directory of Open Access Journals) (2017) Vol. 19, Iss. 3, pp. 87-97
Open Access | Times Cited: 42
MAFLD considerations as a part of the global hepatitis C elimination effort: an international perspective
Yasser Fouad, Jeffrey V. Lazarus, Francesco Negro, et al.
Alimentary Pharmacology & Therapeutics (2021) Vol. 53, Iss. 10, pp. 1080-1089
Open Access | Times Cited: 32
Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis
Patrick Wainwright, Eleonora Scorletti, Christopher D. Byrne
Current Diabetes Reports (2017) Vol. 17, Iss. 4
Closed Access | Times Cited: 38
Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapy
Chung‐Feng Huang, Ming‐Lun Yeh, Cing-Yi Huang, et al.
Medicine (2016) Vol. 95, Iss. 27, pp. e4157-e4157
Open Access | Times Cited: 35
Managing diabetes and liver disease association
Abd Elkhalek Hamed, Medhat Elsahar, Nadia Elwan, et al.
Arab Journal of Gastroenterology (2018) Vol. 19, Iss. 4, pp. 166-179
Closed Access | Times Cited: 35
Page 1 - Next Page

Scroll to top